CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors. Xiong T, Wang G, Yu P, Li Z, et al. J Clin Invest 2025;135:e189920.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiong T, Wang G, Yu P, Li Z, et al. CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors. J Clin Invest 2025;135:e189920.
PMID: 40478751